This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Cushman & Wakefield (CWK) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cushman & Wakefield (CWK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Anywhere Real Estate (HOUS) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Anywhere Real Estate (HOUS) delivered earnings and revenue surprises of -21.59% and 4.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Vornado (VNO) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Vornado's (VNO) Q2 earnings are likely to have benefited from the improved U.S. office market scenario.
FirstService (FSV) Q2 Earnings Lag Estimates
by Zacks Equity Research
FirstService (FSV) delivered earnings and revenue surprises of -4.27% and 1.07%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Boston Properties' (BXP) Q2 Earnings
by Zacks Equity Research
Amid uneven U.S. office market recovery, improving demand for Boston Properties' (BXP) office buildings and life-science assets in key U.S. markets is likely to have driven its Q2 earnings.
Is the Options Market Predicting a Spike in Cushman & Wakefield (CWK) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cushman & Wakefield (CWK) stock based on the movements in the options market lately.
Is Cushman & Wakefield (CWK) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Down 13.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Cushman & Wakefield (CWK)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Cushman & Wakefield (CWK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Cushman & Wakefield (CWK) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Can Cushman & Wakefield (CWK) Climb 36% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 35.9% in Cushman & Wakefield (CWK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Cushman & Wakefield (CWK) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 140% and 7.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for CBRE Group (CBRE) in Q1 Earnings?
by Zacks Equity Research
CBRE Group's (CBRE) Q1 results are likely to reflect the benefits of its broad diversification across property types, lines of business, geographic markets and clients and disciplined expense management.
Cushman & Wakefield (CWK) Stock Moves -1.65%: What You Should Know
by Zacks Equity Research
Cushman & Wakefield (CWK) closed at $17.90 in the latest trading session, marking a -1.65% move from the prior day.
Cushman & Wakefield (CWK) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cushman & Wakefield (CWK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cushman & Wakefield (CWK) Loses 15.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Cushman & Wakefield (CWK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Is CBRE Group (CBRE) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cushman & Wakefield (CWK) Stock Moves -1.98%: What You Should Know
by Zacks Equity Research
Cushman & Wakefield (CWK) closed the most recent trading day at $18.34, moving -1.98% from the previous trading session.
Cushman & Wakefield (CWK) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cushman & Wakefield (CWK) closed at $18.71 in the latest trading session, marking a -1.99% move from the prior day.
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
Prologis' (PLD) Q1 results are likely to reflect the benefits of the company's efforts to leverage the industrial real estate market's healthy fundamentals backed by stellar demand.
Cushman & Wakefield (CWK) Stock Moves -0.78%: What You Should Know
by Zacks Equity Research
Cushman & Wakefield (CWK) closed at $20.34 in the latest trading session, marking a -0.78% move from the prior day.
Cushman & Wakefield (CWK) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cushman & Wakefield (CWK) closed at $20.76, marking a -1.56% move from the previous day.
How Cushman & Wakefield (CWK) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Cushman & Wakefield (CWK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Best Growth Stocks to Buy for March 30th
by Zacks Equity Research
CBRE, CWK, and TGLS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 30, 2022.
4 Reasons to Buy Jones Lang LaSalle (JLL) Stock Right Now
by Zacks Equity Research
Jones Lang LaSalle (JLL) is a prudent investment pick at present as it continues to display robust fundamentals and an improvement in prospects.
Cushman & Wakefield (CWK) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cushman & Wakefield (CWK) closed at $19.93 in the latest trading session, marking a +0.86% move from the prior day.